ARCHIVES

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

This article is from The Cancer Letter archive.

Vol. 25 No. 48 | December 17, 1999

Download PDF Visit The Full Archive

Related Articles

Statistical Models Determine Stem-Cell Transplant Effectiveness

July 26, 2013

Smoking Conference Established Priorities

January 15, 1982

NCI, CDC To Collaborate On Surveillance System.

March 24, 2000

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

Lombardi Recruits Adams-Campbell.

October 3, 2008

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005